Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
631 studies found for:    (pregnancy OR maternal) AND (acquired immunodeficiency syndrome)
Show Display Options
Rank Status Study
21 Completed HIV Testing in Pregnant Women: Evaluating an Opt-Out Testing Strategy
Conditions: HIV;   AIDS Virus;   Pregnancy
Intervention: Procedure: HIV screening in pregnancy
22 Unknown  Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV
Conditions: HIV;   Hepatitis B
Interventions: Drug: Tenofovir/lamivudine/lopinavir-ritonavir;   Drug: Zidovudine/lamivudine/lopinavir-ritonavir
23 Completed Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: ZDV Short (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Short (mother)-Long (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Short (infant): Comparison of zidovudine durations;   Drug: ZDV Long (mother)-Long (infant): Comparison of zidovudine durations
24 Completed Maternal HIV Disclosure to School Children: RCT of Family-based Intervention
Conditions: HIV;   Disclosure
Intervention: Behavioral: Amagugu Counseling Intervention
25 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine
26 Active, not recruiting A Prospective, Observational Study of Pregnancy Outcomes Among Women Exposed to Truvada for PrEP Indication
Condition: HIV Infection
Intervention:
27 Completed Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
Condition: HIV Infections
Intervention: Drug: Routine three-drug antiretroviral prophylaxis
28 Completed Mothers Living With HIV and Their Adolescent Children
Conditions: Family Relations;   Mental Health;   Physical Health;   Risky Sexual Behavior;   Substance Use;   HIV Infections
Intervention: Behavioral: Cognitive-behavioral, small-group format sessions
29 Completed Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV
Condition: HIV Infections
Interventions: Drug: Nevirapine;   Drug: Nevirapine placebo
30 Completed Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa
Condition: HIV
Intervention: Drug: Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
31 Completed Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns
Conditions: HIV Infections;   Pregnancy
Interventions: Drug: Ritonavir;   Drug: Saquinavir;   Drug: Lamivudine;   Drug: Zidovudine
32 Completed Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)
Condition: HIV
Interventions: Drug: Zidovudine (ZDV);   Drug: Nevirapine (NVP);   Drug: Emtricitabine-tenofovir disoproxil fumarate (Truvada [TRV]);   Drug: Lamivudine-Zidovudine (3TC-ZDV);   Drug: Lopinavir-ritonavir (LPV-RTV)
33 Recruiting Antiretroviral Pregnancy Registry (APR)-Risk of Birth Defects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Any Antiretroviral Therapy
34 Completed Trial to Improve Access to PMTCT Services and Reduce HIV Transmission From Mother to Child
Conditions: Mother-to-child Transmission of HIV;   Pregnancy
Interventions: Other: Enhanced CHW intervention;   Other: Standard of care
35 Completed Measuring the Impact of Integrating Maternal and Newborn HIV Testing With Childhood Immunization Services
Condition: HIV
Interventions: Other: HIV testing commodity reinforcement;   Other: Policy reinforcement meeting;   Other: Opt-out HIV testing for mothers and newborns;   Other: Operational support for service integration;   Other: Community sensitization
36 Completed Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva
Condition: HIV Infections
Interventions: Drug: Kaletra (lopinavir/ritonavir);   Drug: Kaletra (lopinavir/ritonavir) + Combivir (zidovudine/lamivudine)
37 Recruiting Implementing a Comprehensive Prevention of Mother-to-Child Transmission of HIV Program for South African Couples
Conditions: HIV;   Pregnancy
Intervention: Behavioral: Protect your family
38 Completed A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in HIV-1 Seropositive Women During the Last Trimester of Pregnancy and Their Newborns
Conditions: HIV Infections;   Pregnancy
Intervention: Drug: CD4-IgG
39 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
40 Completed Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: Cotrimoxazole prophylaxis;   Drug: SP IPT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.